scholarly journals P251 Correlation of FDG PET scanning with clinical and laboratory markers of activity in patients with Crohn's disease

2014 ◽  
Vol 8 ◽  
pp. S167-S168
Author(s):  
E. Russo ◽  
S. Khan ◽  
A. Brown ◽  
N. Keat ◽  
W. Hallett ◽  
...  
Gut ◽  
2014 ◽  
Vol 63 (Suppl 1) ◽  
pp. A74.1-A74
Author(s):  
E Russo ◽  
S Khan ◽  
AP Brown ◽  
N Keat ◽  
W Hallett ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-435
Author(s):  
Evangelos Russo ◽  
Roger N. Gunn ◽  
Sameer Khan ◽  
Ryan Janisch ◽  
Eugenii A. Rabiner ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Katsuya Osone ◽  
Hiroomi Ogawa ◽  
Chika Katayama ◽  
Yuta Shibasaki ◽  
Kunihiko Suga ◽  
...  

Abstract Background No standard treatment for anorectal fistula cancer, such as multidisciplinary therapy, has been established due to the rarity of the disease. Herein, we investigated patients with cancer associated with anorectal fistula who underwent surgery to clarify the clinicopathological characteristics and to propose future perspectives for treatment strategies. Case presentation Seven patients with cancer associated with anorectal fistula who underwent rectal amputation in our institute were analyzed with regard to clinical characteristics, pathological findings, surgical results, and prognosis. Four cases had Crohn's disease as an underlying cause. All seven cases were diagnosed as advanced stage. Preoperative [18F]-fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography/computed tomography (FDG-PET/CT) showed abnormal FDG accumulation in six cases including four mucinous adenocarcinomas. Three cases that received preoperative hyperthermo-chemoradiotherapy achieved pathological R0 resection. Postoperative recurrence was observed in four cases including three with Crohn's disease and one resulting in death. Conclusions Anorectal fistula cancer is rare and difficult to be diagnosed at early stages. Mucinous adenocarcinoma associated with anorectal fistula tends to exhibit abnormal FDG accumulation by FDG-PET/CT unlike common colorectal mucinous adenocarcinoma. Preoperative hyperthermo-chemoradiotherapy may be effective in obtaining pathological complete resection.


2004 ◽  
Vol 19 (10) ◽  
pp. 1063-1071 ◽  
Author(s):  
T. M. Trebble ◽  
S. A. Wootton ◽  
M. A. Stroud ◽  
M. A. Mullee ◽  
P. C. Calder ◽  
...  

2015 ◽  
Vol 26 (3) ◽  
pp. 279-280
Author(s):  
Mevlut Kurt ◽  
Emrah Posul ◽  
Guray Can ◽  
Bulent Yilmaz ◽  
Ugur Korkmaz ◽  
...  

2000 ◽  
Vol 118 (4) ◽  
pp. A320 ◽  
Author(s):  
Markus F. Neurath ◽  
Martin Vehling ◽  
Klaus Schunk ◽  
Holger Brockmann ◽  
Thomas Orth ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S998
Author(s):  
Shinichiro Yoshioka ◽  
Keiichi Mitsuyama ◽  
Kotaro Kuwaki ◽  
Ryosuke Yamauchi ◽  
Hiroshi Yamasaki ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Liran Domachevsky ◽  
Haim Leibovitzh ◽  
Irit Avni-Biron ◽  
Lev Lichtenstein ◽  
Natalia Goldberg ◽  
...  

Background. To investigate the association between 18F-FDG (Fluorodeoxyglucose) PET (positron emission tomography)/MRE (magnetic resonance enterography) metrics with the inflammatory biomarkers fecal calprotectin and C-reactive protein (CRP) in patients with Crohn’s disease (CD). Methods. This prospective pilot study was institutional review board (IRB) approved with informed consent obtained. Consecutive CD patients were referred to 18F-FDG PET/MRE. Patients in whom colonoscopy was performed and CRP and fecal calprotectin levels were measured were included. CRP and fecal calprotectin were regarded as positive for inflammation if they were greater than 0.5 mg/dl and 150 mcg/g, respectively. Correlation of quantitative variables was performed using the Pearson’s correlation coefficient. Receiver operating characteristic (ROC) curves were drawn and the area under the curve (AUC) was calculated to evaluate the accuracy of PET and MRE metrics in determining the presence of inflammation evaluated by calprotectin and CRP levels. Results. Analysis of 21 patients (16 women and 5 men, 43±18 years) was performed. Magnetic resonance index of activity (MaRIA) score had an AUC of 0.63 associated with fecal calprotectin and CRP. Adding apparent diffusion coefficient (ADC) and metabolic inflammatory volume (MIV) to MaRIA score resulted in an AUC of 0.92 with a cutoff value of 447 resulting in 83% and 100% sensitivity and specificity, respectively. Conclusion. The addition of ADC and MIV to the MaRIA score increases the accuracy for discrimination of disease activity in patients with CD. Trial registration number is 2015062.


Sign in / Sign up

Export Citation Format

Share Document